Quantcast

Latest Vagus nerve stimulation Stories

2011-05-25 08:00:00

HOUSTON, May 25, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in epilepsy management, today announced it will participate in the 2011 Jefferies Global Healthcare Conference on Wednesday, June 8, 2011, in New York. Greg Browne, Cyberonics' Senior Vice President, Finance & Chief Financial Officer, will speak to the attendees of the conference at 10:30 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations...

2011-05-10 08:00:00

HOUSTON, May 10, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) today announced that the company will report financial results for the fourth quarter and fiscal year ended April 29, 2011, on Thursday, June 2, 2011, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fourth Quarter and Fiscal Year 2011 Results Conference Call Instructions The conference call will be...

2011-05-02 08:00:00

HOUSTON, May 2, 2011 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX), a global leader in epilepsy management, today announced the first implant of its AspireSR(TM) seizure response product on April 27, 2011. The implant, conducted under the care of Professors Paul Boon and Dirk Van Roost and their teams at the Ghent University Epilepsy Group in Ghent, Belgium, was received by a patient with ictal tachycardia (heart rate increases associated with seizures) who has been suffering with...

2011-04-19 12:39:17

Associated with early seizure onset and cognitive impairment A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE). According to the Centers for Disease Control and...

2011-04-04 07:00:00

BELMONT, Calif., April 4, 2011 /PRNewswire/ -- Ventus Medical, Inc. today reported positive results from a 19 center clinical trial using its FDA-cleared Provent® Sleep Apnea Therapy device to treat obstructive sleep apnea. Provent Therapy uses the patient's own breathing to create expiratory positive airway pressure (EPAP) to keep the airway open during sleep. The full results of this three month study were published in the April 2011 issue of the peer-reviewed medical...

2011-02-17 08:00:00

HOUSTON, Feb. 17, 2011 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the Citi 2011 Global Health Care Conference in New York on Thursday, March 3, 2011 at 11:00 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investors link on the Cyberonics home page at http://www.cyberonics.com on March 3, 2011. The conference...

2011-02-09 08:00:00

HOUSTON, Feb. 9, 2011 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the third quarter ended January 28, 2011 of its fiscal year ending April 29, 2011, on Wednesday, March 2, 2011, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 7:30 AM Central Time (8:30 AM Eastern Time). Fiscal Year 2011 Third Quarter Results Conference Call Instructions The...

2011-02-01 15:46:00

HOUSTON, Feb. 1, 2011 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the AspireHC(TM) (High Capacity) generator for use in vagus nerve stimulation (VNS) therapy was approved by the United States Food and Drug Administration (FDA) for commercial release. The AspireHC generator (development name NXT HC) represents the fifth generation of VNS Therapy® technology. This product incorporates greater functionality for the benefit of patients and their...

72e5b5d177e96a995617a19f12675ac2
2011-01-13 05:55:00

Researchers have identified a way to ease tinnitus, or ringing in the ears, by stimulating a nerve in the neck while simultaneously playing certain sounds over an extended period of time.  These measures work together to essentially "reboot" the brain, the scientists said. Tinnitus affects as many as 23 million U.S. adults, including one in 10 seniors and 40 percent of military veterans.  The hallmark of the condition, which is currently incurable, is often a persistent ringing in...

2011-01-12 18:18:03

Millions affected by hearing disorder Targeted nerve stimulation could yield a long-term reversal of tinnitus, a debilitating hearing impairment affecting at least 10 percent of senior citizens and up to 40 percent of military veterans, according to an article posted in the Jan. 12 online edition of Nature. Researchers Dr. Michael Kilgard and Dr. Navzer Engineer from The University of Texas at Dallas and University-affiliated biotechnology firm MicroTransponder report that stimulation of the...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related